Two Sigma Investments
TBIO

Two Sigma Investments’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Two Sigma Investments’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-770
Closed -$21.9K – 3303
2023
Q2 		$21.9K Sell
770
-505
-40% -$20.2K ﹤0.01% 2901
2023
Q1 		$71.1K Sell
1,275
-1,188
-48% -$42.1K ﹤0.01% 2711
2022
Q4 		$53.2K Sell
2,463
-809
-25% -$22K ﹤0.01% 2583
2022
Q3 		$98K Buy
+3,272
New +$115K ﹤0.01% 2237

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments's TBIO Position: Q3 2023 in Review

Two Sigma Investments sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2023, closing a stake of 770 shares — an estimated $21.9K sold.

Two Sigma Investments first reported a position in TBIO in Q3 2022 and held it in 4 quarters. The position peaked at $98K in Q3 2022. 25 funds tracked by Wall St. Rank hold TBIO as of Q3 2023.

  • Two Sigma Investments reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Investments sold 770 Telesis Bio, Inc. Common Stock shares in Q3 2023, an estimated $21.9K.
  • Two Sigma Investments first reported a position in Telesis Bio, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Two Sigma Investments's Telesis Bio, Inc. Common Stock position peaked at $98K in Q3 2022.
  • 25 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.